The OPTIMAL Randomized Controlled Trial — OPTIMAL

Left Main Coronary Artery Stenosis Clinical Trial

Official title:
OPtimizaTIon of Left MAin PCI With IntravascuLar Ultrasound. The OPTIMAL Randomized Controlled Trial

Status Active, not recruiting

Clinical Trial Summary

The OPTIMAL study is a randomized, controlled, multicentre, international study. A total of 800 patients will be randomized in a 1:1 fashion to Intravascular Ultrasound (IVUS)-guided PCI versus qualitative angio(QCA)-guided Percutaneous Coronary Intervention (PCI). Patients will be consented prior to the PCI procedure and then followed up to 2 years after the index procedure. Patients will be followed-up at 1 month (telephone contact), 12 months (outpatient clinic visit or telephone call) and 24 months (outpatient clinic visit or telephone call) after the index procedure.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Coronary Stenosis
Left Main Coronary Artery Stenosis

Clinical Trial Details

NCT number	NCT04111770
Study type	Interventional
Source	ECRI bv
Contact
Status	Active, not recruiting
Phase	N/A
Start date	July 8, 2020
Completion date	July 2025

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT02765646` - eTryton Left Main Registry Tryton Side Branch Stent® Tmt of Denovo CAD in LM and CFX Arteries
Completed	`NCT04248777` - Optical Coherence Tomography - Guided Protocol for Left Main Percutaneous Coronary Intervention	N/A
Not yet recruiting	`NCT05650411` - P2Y12 Inhibitor-based Single Antiplatelet Therapy After a Short DAPT vs. Conventional DAPT Following PCI With a Polymer-free Drug-coated Stent for Unprotected Left Main Coronary Artery Disease (ULTRA-LM)	N/A
Active, not recruiting	`NCT03767621` - Concordance Between FFR and iFR for the Assessment of Intermediate Lesions in the Left Main Coronary Artery. A Prospective Validation of a Default Value for iFR